BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 24075834)

  • 1. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma.
    Caramel J; Papadogeorgakis E; Hill L; Browne GJ; Richard G; Wierinckx A; Saldanha G; Osborne J; Hutchinson P; Tse G; Lachuer J; Puisieux A; Pringle JH; Ansieau S; Tulchinsky E
    Cancer Cell; 2013 Oct; 24(4):466-80. PubMed ID: 24075834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cordycepin (3'-deoxyadenosine) suppressed HMGA2, Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b.
    Zhang P; Huang C; Fu C; Tian Y; Hu Y; Wang B; Strasner A; Song Y; Song E
    Oncotarget; 2015; 6(12):9834-53. PubMed ID: 25868853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
    Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
    J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression.
    Denecker G; Vandamme N; Akay O; Koludrovic D; Taminau J; Lemeire K; Gheldof A; De Craene B; Van Gele M; Brochez L; Udupi GM; Rafferty M; Balint B; Gallagher WM; Ghanem G; Huylebroeck D; Haigh J; van den Oord J; Larue L; Davidson I; Marine JC; Berx G
    Cell Death Differ; 2014 Aug; 21(8):1250-61. PubMed ID: 24769727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells.
    Perrot CY; Gilbert C; Marsaud V; Postigo A; Javelaud D; Mauviel A
    Pigment Cell Melanoma Res; 2013 Nov; 26(6):861-73. PubMed ID: 23890107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
    Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
    Morel AP; Hinkal GW; Thomas C; Fauvet F; Courtois-Cox S; Wierinckx A; Devouassoux-Shisheboran M; Treilleux I; Tissier A; Gras B; Pourchet J; Puisieux I; Browne GJ; Spicer DB; Lachuer J; Ansieau S; Puisieux A
    PLoS Genet; 2012; 8(5):e1002723. PubMed ID: 22654675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6-induced Twist and N-cadherin enhance melanoma cell metastasis.
    Na YR; Lee JS; Lee SJ; Seok SH
    Melanoma Res; 2013 Dec; 23(6):434-43. PubMed ID: 24051540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological roles and prognostic values of the epithelial-mesenchymal transition-mediating transcription factors Twist, ZEB1 and Slug in diffuse large B-cell lymphoma.
    Lemma S; Karihtala P; Haapasaari KM; Jantunen E; Soini Y; Bloigu R; Pasanen AK; Turpeenniemi-Hujanen T; Kuittinen O
    Histopathology; 2013 Jan; 62(2):326-33. PubMed ID: 23190132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical study of NFE2L2, KEAP1 and 8-hydroxy-2'-deoxyguanosine and the EMT markers SNAI2, ZEB1 and TWIST1 in metastatic melanoma.
    Hintsala HR; Haapasaari KM; Soini Y; Karihtala P
    Histol Histopathol; 2017 Feb; 32(2):129-136. PubMed ID: 27170270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of microRNAs involved in epithelial-mesenchymal transition of HT-29 cell line.
    Cai ZG; Zhang SM; Zhang H; Zhou YY; Wu HB; Xu XP
    Cell Biol Int; 2013 Jul; 37(7):669-74. PubMed ID: 23483606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
    Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme 2 attenuates the metastasis of non-small cell lung cancer through inhibition of epithelial-mesenchymal transition.
    Qian YR; Guo Y; Wan HY; Fan L; Feng Y; Ni L; Xiang Y; Li QY
    Oncol Rep; 2013 Jun; 29(6):2408-14. PubMed ID: 23545945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
    Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer.
    Schmalhofer O; Brabletz S; Brabletz T
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):151-66. PubMed ID: 19153669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.
    Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y
    Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.
    Castilla MÁ; Moreno-Bueno G; Romero-Pérez L; Van De Vijver K; Biscuola M; López-García MÁ; Prat J; Matías-Guiu X; Cano A; Oliva E; Palacios J
    J Pathol; 2011 Jan; 223(1):72-80. PubMed ID: 21125666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.